Anesthesia for endovascular neurosurgery

Neurosurgery

Volumn 59, Issue 5 SUPPL., 2006, Pages

  Armonda, Rocco A ^a   Vo, Alexander H ^b   Dunford, John ^a   Bell, Randy S ^a  

^a WALTER REED ARMY MEDICAL CENTER   (United States)

^b Uniformed Services University   (United States)

Author keywords

Anesthesiologist; Endovascular neurosurgeon; Neuroanesthetist; Neurointerventionalist

Indexed keywords

ABCIXIMAB; ACUPRIN; ALFENTANIL; ALTEPLASE; ANTITHROMBOCYTIC AGENT; BENZODIAZEPINE DERIVATIVE; CALCIUM CHANNEL BLOCKING AGENT; CLOPIDOGREL; DEXMEDETOMIDINE; DIAZEPAM; EPTIFIBATIDE; ESMOLOL; ETOMIDATE; FENTANYL; GLYCERYL TRINITRATE; HALOTHANE; HYDRALAZINE; LABETALOL; LIDOCAINE; LORAZEPAM; MAGNESIUM; MIDAZOLAM; NICARDIPINE; NIMODIPINE; NITRIC OXIDE; NITROPRUSSIDE SODIUM; NITROUS OXIDE; OPIATE; PHENYLEPHRINE; PLASMINOGEN ACTIVATOR; PROPOFOL; REMIFENTANIL; SEVOFLURANE; SUFENTANIL; THIOPENTAL; TICLOPIDINE; TIROFIBAN; UNINDEXED DRUG;

ANESTHESIA; ANESTHESIST; ANTICOAGULATION; BRADYCARDIA; BRAIN HEMORRHAGE; BRAIN INFARCTION; DENTAL ANESTHESIA; DRUG ELIMINATION; DRUG ERUPTION; DRUG FATALITY; ENDOCRINE DISEASE; ENDOVASCULAR SURGERY; GENERAL ANESTHESIA; HEMODYNAMIC MONITORING; HUMAN; HYPOTENSION; HYPOTHERMIA; NEUROLOGIC DISEASE; NEURORADIOLOGY; NEUROSURGERY; NEUTROPENIA; NONHUMAN; OPERATING ROOM; PATIENT TRANSPORT; POSTOPERATIVE NAUSEA AND VOMITING; PRIORITY JOURNAL; REVIEW; THROMBOCYTOPENIA; URTICARIA; VASOSPASM;

EID: 33750338121     PISSN: 0148396X     EISSN: None     Source Type: Journal    
DOI: 10.1227/01.NEU.0000237337.38375.90     Document Type: Review

References (95)

1. Artru AA, Nugent M, Michenfelder JD: Anesthetics affect the cerebral metabolic response to circulatory catecholamines. J Neurochem 36:1941-1946, 1981.
2. Auer LM, Pfurtscheller G, Abobaker S, Ott E, Marguc KJ, Lechner H: Penumbra around chronic cerebral infarction? Neurol Res 10:246-251, 1988.
3. Azmi-Ghadimi H, Heary RF, Farkas JE, Hunt CD: Use of intraventricular tissue plasminogen activator and Guglielmi detachable coiling for the acute treatment of casted ventricles from cerebral aneurysm hemorrhage: Two technical case reports. Neurosurgery 50:421-424, 2002.
4. Bachet J, Guilmet D, Goudot B, Termignon JL, Teodori G, Dreyfus G, Brodaty D, Dubois C, Delentdecker P: Cold cerebroplegia. A new technique of cerebral protection during operations on the transverse aortic arch. J Thorac Cardiovasc Surg 102:85-93, 1991.
5. Barker FG, Ogilvy CS: Efficacy of prophylactic nimodipine for delayed ischemic deficit after subarachnoid hemorrhage: A metaanalysis. J Neurosurg 84:405-414, 1996.
6. Berlis A, Lutsep H, Barnwell S, Norbash A, Wechsler L, Jungreis CA, Woolfenden A, Redekop G, Hartmann M, Schumacher M: Mechanical thrombolysis in acute ischemic stroke with endovascular photoacoustic recanalization. Stroke 35:1112-1116, 2004.
7. Bustillo MA, Lazar RM, Finck AD, Fitzsimmons B, Berman MF, Pile-Spellman J, Heyer EJ: Dexmedetomidine may impair cognitive testing during endovascular embolization of cerebral arteriovenous malformations: A retrospective case report series. J Neurosurg Anesthesiol 14:209-212, 2002.
8. Clifton GL, Miller ER, Choi SC, Levin HS, McCauley S, Smith KR Jr, Muizelaar JP, Marion DW, Luerssen TG: Hypothermia on admission in patients with severe brain injury. J Neurotrauma 19:293-301, 2002.
9. Clifton GL, Miller ER, Choi SC, Levin HS, McCauley S, Smith KR Jr, Wagner FC, Marion DW, Luerssen TG, Chestnut RM, Schwartz M: Lack of effect of induction of hypothermia after acute brain injury. N Engl J Med 344:556-563, 2001.
10. Crowther CA, Hiller JE, Doyle LW, Haslam RR: Effect of magnesium sulfate given for neuroprotection before preterm birth: A randomized controlled trial. JAMA 290:2669-2676, 2003.
11. Denton MD, Mauiyyedi S, Bazari H: Heparin-induced skin necrosis in a patient with end-stage renal failure and functional protein S deficiency. Am J Nephrol 21:289-293, 2001.
12. Despotis GJ, Gravlee G, Filos K, Levy J: Anticoagulation monitoring during cardiac surgery: A review of current and emerging techniques. Anesthesiology 91:1122-1151, 1999.
13. Dirnagl U, Pulsinelli W: Autoregulation of cerebral blood flow in experimental focal brain ischemia. J Cereb Blood Flow Metab 10:327-336, 1990.
14. du Plessis AJ, Newburger J, Hickey P, Jonas RA, Volpe JJ: Cerebral oxygenation during hypothermic cardiopulmonary bypass: Clinical findings support mathematical model. Anesthesiology 84:1008-1009, 1996.
15. Fried E, Amorim P, Chambers G, Cottrell JE, Kass IS: The importance of sodium for anoxic transmission damage in rat hippocampal slices: Mechanisms of protection by lidocaine. J Physiol 489:557-565, 1995.
16. Funato H, Kawano H, Akada Y, Katsuki Y, Sato M, Uemura A: Effects of a calcium antagonist, lacidipine, on experimental focal cerebral ischemia in rats. Jpn J Pharmacol 75:415-423, 1997.
17. Fujii Y, Takeuchi S, Koike T, Nishimaki K, Ito Y, Tanaka R, Okamoto K: Heparin administration and monitoring for neuroangiography. Am J Neuroradiol 15: 51-54, 1994.
18. Edelman GJ, Hoffman WE, Charbel FT: Cerebral hypoxia after etomidate administration and temporary cerebral artery occlusion. Anesth Analg 85: 821-825, 1997.
19. Feigin VL, Rinkel GJ, Algra A, Vermeulen M, van Gijn J: Calcium antagonists n patients with aneurysmal subarachnoid hemorrhage: A systematic review. Neurology 50:876-883, 1998.
20. Gailani D, Reese EP: Anticoagulant-induced skin necrosis in a patient with hereditary deficiency of protein S. Am J Hematol 60:231-236, 1999.
21. Gomi S, Burnett MG, Karp A, Greenberg JH: Nimodipine does not affect the flow-metabolism couple in permanent cerebral ischemia. Exp Brain Res 155:469-476, 2004.
22. Gorelick PB, Ruland S: IMAGES and FAST-MAG: Magnesium for acute ischaemic stroke. Lancet Neurol 3:330,2004.
23. Gravlee GP, Rogers AT, Dudas LM, Taylor R, Roy RC, Case LD, Triscott M, Brown CW, Mark LJ, Cordell AR: Heparin management protocol for cardiopulmonary bypass influences postoperative heparin rebound but not bleeding. Anesthesiology 76:393-401, 1992.
24. Grillo P, Bruder N, Auquier P, Pellissier D, Gouin F: Esmolol blunts the cerebral blood flow velocity increase during emergence from anesthesia in neurosurgical patients. Anesth Analg 96:1145-1149, 2003.
25. Grocott HP, Mackensen GB, Grigore AM, Mathew J, Reves JG, Phillips-Bute B, Simth PK, Newman MF: Neurologic Outcome Research Group (NORG): Cardiothoracic Anesthesiology Research Endeavors (CARE) Investigators' of the Duke Heart Center. Postoperative hyperthermia is associated with cognitive dysfunction after coronary artery bypass graft surgery. Stroke 33:537-541, 2002.
26. Gronert GA, Michenfelder JD, Sharbrough FW, Milde JH: Canine cerebral metabolic tolerance during 24 hours deep pentobarbital anesthesia. Anesthesiology 55:110-113, 1981.
27. Gustafson C, Ahlgren I, Aronsen KF, Rosberg B: Haemodynamic effects of labetalol-induced hypotension in the anaesthetized dog. Br J Anaesth 53: 585-590, 1981.
28. Guterman LR, Hopkins LN: Endovascular treatment of cerebral aneurysms. Diagnosis and treatment. Clin Neurosurg 40:56-83, 1993.
29. Hajat C, Hajat S, Sharma P: Effects of poststroke pyrexia on stroke outcome: A meta-analysis of studies in patients. Stroke 31:410-414, 2000.
30. Haley EC Jr, Kassell NF, Torner JC: A randomized controlled trial of high-dose intravenous nicardipine in aneurysmal subarachnoid hemorrhage. A report of the Cooperative Aneurysm Study. J Neurosurg 78:537-547, 1993.
31. Haley EC Jr, Kassell NF, Torner JC: A randomized trial of nicardipine in subarachnoid hemorrhage: Angiographic and transcranial Doppler ultrasound results. A report of the Cooperative Aneurysm Study. J Neurosurg 78:548-553, 1993.
32. Haley EC Jr, Kassell NF, Torner JC, Truskowski LL, Germanson TP: A randomized trial of two doses of nicardipine in aneurysmal subarachnoid hemorrhage. A report of the Cooperative Aneurysm Study. J Neurosurg 80:788-796, 1994.
33. Harrigan MR, Levy EI, Bendok BR, Hopkins LN: Bivalirudin for endovascular intervention in acute ischemic stroke: Case report. Neurosurgery 54:218-222, 2004.
34. Hartung J, Cottrell JE: Tirilazad and subarachnoid hemorrhage. J Neurosurg 92:508, 2000.
35. Heran NS, Song JK, Namba K, Smith W, Niimi Y, Berenstein A: The utility of DynaCT in neuroendovascular procedures. AJNR Am J Neuroradiol 27:330-332, 2006.
36. Hoffman WE, Charbel FT, Edelman G, Misra M, Ausman JI: Comparison of the effect of etomidate and desflurane on brain tissue gases and pH during prolonged middle cerebral artery occlusion. Anesthesiology 88:1188-1194, 1998.
37. Hofmann R, Kerschner K, Steinwender C, Kypta A, Bibl D, Leisch F: Abciximab bolus injection does not reduce cerebral ischemic complications of elective carotid artery stenting: A randomized study. Stroke 33: 725-727, 2002.
38. Ibbotson T, McGavin JK, Goa KL: Abciximab: An updated review of its therapeutic use in patients with ischaemic heart disease undergoing percutaneous coronary revascularisation. Drugs 63:1121-1163, 2003.
39. Ibbotson T, McGavin JK, Goa KL: Spotlight on abciximab in patients with ischemic heart disease undergoing percutaneous coronary revascularization. Am J Cardiovasc Drugs 3:381-386, 2003.
40. Inoue O, Taguchi H, Watanabe T, Hosoi R, Kobayashi K, Nishimura T, Gee A: Uncoupling of flow and metabolism induced by sodium nitroprusside in rat cerebral cortex. Neuroreport 15:141-145, 2004.
41. Islam MA, Blankenship JC, Balog C, Iliadis EA, Lincoff AM, Tcheng JE, Califf RM, Topol EJ: EPISTENT Investigators. Effect of abciximab on angiographic complications during percutaneous coronary stenting in the Evaluation of Platelet IIb/IIIa Inhibition in Stenting Trial (EPISTENT). Am J Cardiol 90:916-921, 2002.
42. Junghans U, Seitz RJ, Ritzl A, Wittsack HJ, Fink GR, Freund HJ, Siebler M: Ischemic brain tissue salvaged from infarction by the GP IIb/IIIa platelet antagonist tirofiban. Neurology 58:474-476, 2002.
43. Karlsson BR, Forsman M, Roald OK, Heier MS, Steen PA: Effect of dexmedetomidine, a selective and potent alpha 2-agonist, on cerebral blood flow and oxygen consumption during halothane anesthesia in dogs. Anesth Analg 71:125-129, 1990.
44. Kawaguchi M, Kimbro JR, Drummond JC, Cole DJ, Kelly PJ, Patel PM: Isoflurane delays but does not prevent cerebral infarction in rats subjected to focal ischemia. Anesthesiology 92:1335-1342, 2000.
45. Kereiakes DJ, Lincoff AM, Anderson KM, Achenbach R, Patel K, Barnathan E, Califf RM, Topol EJ, EPIC Investigators, EPILOG Investigators, EPISTENT Investigators: Abciximab survival advantage following percutaneous coronary intervention is predicted by clinical risk profile. Am J Cardiol 90:628-630, 2002.
46. Kilpatrick MM, Lowry DW, Firlik AD, Yonas H, Marion DW: Hyperthermia in the neurosurgical intensive care unit. Neurosurgery 47:850-855, 2000.
47. Kittaka M, Giannotta SL, Zelman V, Correale JD, DeGiorgio CM, Weiss MH, Zlokovic BV: Attenuation of brain injury and reduction of neuron-specific enolase by nicardipine in systemic circulation following focal ischemia and reperfusion in a rat model. J Neurosurg 87:731-737, 1997.
48. Klementavicius R, Nemoto EM, Yonas H: Basal Q10 for cerebral metabolic rate for oxygen (CMRO2) in rats. Adv Exp Med Biol 388:191-195, 1996.
49. Klementavicius R, Nemoto EM, Yonas H: The Q10 ratio for basal cerebral metabolic rate for oxygen in rats. J Neurosurg 85:482-487, 1996.
50. Knoll T, Wimmer ML, Gumpinger F, Haberl RL: The low normothermia concept-Maintaining a core body temperature between 36 and 37 degrees C in acute stroke unit patients. J Neurosurg Anesthesiol 14:304-308, 2002.
51. Kwon BJ, Han MH, Oh CW, Kim KH, Chang KH: Procedure-related haemorrhage in embolisation of intracranial aneurysms with Guglielmi detachable coils. Neuroradiology 45:562-569, 2003.
52. Lei B, Cottrell JE, Kass IS: Neuroprotective effect of low-dose lidocaine in a rat model of transient focal cerebral ischemia. Anesthesiology 95:445-451, 2001.
53. Lei B, Popp S, Capuano-Waters C, Cottrell JE, Kass IS: Effects of delayed administration of low-dose lidocaine on transient focal cerebral ischemia in rats. Anesthesiology 97:1534-1540, 2002.
54. Lei B, Popp S, Capuano-Waters C, Cottrell JE, Kass IS: Lidocaine attenuates apoptosis in the ischemic penumbra and reduces infarct size after transient focal cerebral ischemia in rats. Neuroscience 125:691-701, 2004.
55. Lutz LJ, Milde JH, Milde LN: The cerebral functional, metabolic, and hemodynamic effects of desflurane in dogs. Anesthesiology 73:125-131, 1990.
56. Ma D, Hossain M, Rajakumaraswamy N, Arshad M, Sanders RD, Franks NP, Maze M: Dexmedetomidine produces its neuroprotective effect via the alpha(2A)-adrenoceptor subtype. Eur J Pharmacol 502:87-97, 2004.
57. Mack PF, Perrine K, Kobylarz E, Schwartz TH, Lien CA: Dexmedetomidine and neurocognitive testing in awake craniotomy. J Neurosurg Anesthesiol 16:20-25, 2004.
58. Markgraf CG, Clifton GL, Moody MR: Treatment window for hypothermia in brain injury. J Neurosurg 95:979-983, 2001.
59. Moliterno DJ, Chan AW: Glycoprotein IIb/IIIa inhibition in early intent-to-stent treatment of acute coronary syndromes: EPISTENT, ADMIRAL, CADILLAC, and TARGET. J Am Coll Cardiol 41(Suppl 4):49S-54S, 2003.
60. Muir KW: Magnesium for neuroprotection in ischaemic stroke: Rationale for use and evidence of effectiveness. CNS Drugs 15:921-930, 2001.
61. Muir KW, Lees KR, Ford I, Davis S: Magnesium for acute stroke (Intravenous Magnesium Efficacy in Stroke trial): Randomised controlled trial. Lancet 363:439-445, 2004.
62. Nemoto EM, Klementavicius R, Yonas H: Effects of hypothermia on cerebral metabolic rate for oxygen. J Neurosurg Anesthesiol 6:220-223, 1994.
63. Nemoto EM, Klementavicius R, Yonas H: Functional and basal cerebral metabolic rate for oxygen (CMRO2) and its relevance to the pathogenesis and therapy of brain injury. Adv Exp Med Biol 454:235-242, 1998.
64. Nemoto EM, Klementavicius R, Melick JA, Yonas H: Effect of mild hypothermia on active and basal cerebral oxygen metabolism and blood flow. Adv Exp Med Biol 361:469-473, 1994.
65. Nemoto EM, Klementavicius R, Melick JA, Yonas H: Norepinephrine activation of basal cerebral metabolic rate for oxygen (CMRO2) during hypothermia in rats. Anesth Analg 83:1262-1267, 1996.
66. Nemoto EM, Klementavicius R, Melick JA, Yonas H: Suppression of cerebral metabolic rate for oxygen (CMRO2) by mild hypothermia compared with thiopental. J Neurosurg Anesthesiol 8:52-59, 1996.
67. Newburger JW, Jonas RA, Wernovsky G, Wypij D, Hickey PR, Kuban KC, Farrell DM, Holmes GL, Helmers SL, Constantinou J, Enrique C, Barlow J, Walsh AZ, Lucius KC, Share JC, Wessel DL, Hanley FL, Mayer JE, Castaneda AR, Ware JH: A comparison of the perioperative neurologic effects of hypothermic circulatory arrest versus low-flow cardiopulmonary bypass in infant heart surgery. N Engl J Med 329:1057-1064, 1993.
68. Olesen J: The effect of intracarotid epinephrine, norepinephrine, and angiotensin on the regional cerebral blood flow in man. Neurology 22:978-987, 1972.
69. Olsen KS, Svendsen LB, Larsen FS, Paulson OB: Effect of labetalol on cerebral blood flow, oxygen metabolism and autoregulation in healthy humans. Br J Anaesth 75:51-54, 1995.
70. Penttila J, Helminen A, Anttila M, Hinkka S, Scheinin H: Cardiovascular and parasympathetic effects of dexmedetomidine in healthy subjects. Can J Physiol Pharmacol 82:359-362, 2004.
71. Perl J, Samples SD: Thrombolytic therapy for acute ischemic stroke. Tech Vasc Interv Radiol 4:115-121, 2001.
72. Price DJ, Campbell PG, Sutton AG, Grech ED, Davies A, Hall JA, De Belder MA: Selective use of abciximab in coronary stenting: Overall outcomes can still be equivalent to those in the EPISTENT treatment group. Int J Cardiovasc Intervent 4:15-20, 2001.
73. Qureshi AI, Luft AR, Sharma M, Guterman LR, Hopkins LN: Prevention and treatment of thromboembolic and ischemic complications associated with endovascular procedures: Part I-Pathophysiological and pharmacological features. Neurosurgery 46:1344-1359, 2000.
74. Qureshi AI, Saad M, Zaidat OO, Suarez JI, Alexander MJ, Fareed M, Suri K, Ali Z, Hopkins LN: Intracerebral hemorrhages associated with neurointerventional procedures using a combination of antithrombotic agents including abciximab. Stroke 33:1916-1919, 2002.
75. Qureshi AI, Wilson DA, Hanley DF, Traystman RJ: Pharmacologic reduction of mean arterial pressure does not adversely affect regional cerebral blood flow and intracranial pressure in experimental intracerebral hemorrhage. Crit Care Med 27:965-971, 1999.
76. Raley-Susman KM, Kass IS, Cottrell JE, Newman RB, Chambers G, Wang J: Sodium influx blockade and hypoxic damage to CA1 pyramidal neurons in rat hippocampal slices. J Neurophysiol 86:2715-2726, 2001.
77. Ringer AJ, Hopkins LN: Endovascular treatment of acute stroke. J Am Coll Surg 194 [Suppl 1]:S15-S21, 2002.
78. Sahlin C, Delgado T, Owman C, Svendgaard NA: Changes in cerebral blood flow and metabolism following intraarterial or local administration of nimodipine, before and after experimental subarachnoid hemorrhage in baboons. Stroke 17:220-224, 1986.
79. Sato K, Kato M: Re-bleeding during embolization of ruptured cerebral aneurysms by Guglielmi detachable coil [in Japanese]. Masui 51:1238-1242, 2002.
80. Saver JL, Kidwell C, Eckstein M, Starkman S: Prehospital neuroprotective therapy for acute stroke: results of the Field Administration of Stroke Therapy-Magnesium (FAST-MAG) pilot trial. Stroke 35:e106-e108, 2004.
81. Schanne FA, Kane AB, Young EE, Farber JL: Calcium dependence of toxic cell death: A final common pathway. Science 206:700-702, 1979.
82. Schroeder T, Schierbeck J, Howardy P, Knudsen L, Skafte-Holm P, Gefke K: Effect of labetalol on cerebral blood flow and middle cerebral arterial flow velocity in healthy volunteers. Neurol Res 13:10-12, 1991.
83. Schumacher HC, Meyers PM, Yavagal DR, Harel NY, Elkind MS, Mohr JP, Pile-Spellman J: Endovascular mechanical thrombectomy of an occluded superior division branch of the left MCA for acute cardioembolic stroke. Cardiovasc Intervent Radiol 26:305-308, 2003.
84. Schwarz S, Hafner K, Aschoff A, Schwab S: Incidence and prognostic significance of fever following intracerebral hemorrhage. Neurology 54:354-361, 2000.
85. Spearman MP, Jungreis CA, Wehner JJ, Gerszten PC, Welch WC: Endovascular thrombolysis in deep cerebral venous thrombosis. AJMR Am J Neuroradiol 18:502-506, 1997.
86. Srinivasan AF, Rice L, Bartholomew JR, Rangaswamy C, La Perna L, Thompson JE, Murphy S, Baker KR: Warfarin-induced skin necrosis and venous limb gangrene in the setting of heparin-induced thrombocytopenia. Arch Intern Med 164:66-70, 2004.
87. Stange K, Lagerkranser M, Sollevi A: Nitroprusside-induced hypotension and cerebrovascular autoregulation in the anesthetized pig. Anesth Analg 73:745-752, 1991.
88. Suarez JI, Zaidat OO, Sunshine JL, Tarr R, Selman WR, Landis DM: Endovascular administration after intravenous infusion of thrombolytic agents for the treatment of patients with acute ischemic strokes. Neurosurgery 50:251-259, 2002.
89. Toda N: Dopamine vasodilates human cerebral artery. Experientia 39:1131-1132, 1983.
90. Tulleken CA, van Dieren A, ten Veen J, Lopes da Silva FH: Changes in local cerebral blood flow, local EEG, and flow in the distal stump of the middle cerebral artery in cats with occlusion of the middle cerebral artery. Acta Neurochir (Wien) 61:227-240, 1982.
91. Vandesteene A, Trempont V, Engelman E, Deloof T, Focroul M, Schoutens A, de Rood M: Effect of propofol on cerebral blood flow and metabolism in man. Anaesthesia 43 [Suppl]:42-43, 1988.
92. Venn RM, Grounds RM: Comparison between dexmedetomidine and propofol for sedation in the intensive care unit: Patient and clinician perceptions. Br J Anaesth 87:684-690, 2001.
93. Veyna RS, Seyfried D, Burke DG, Zimmerman C, Mlynarek M, Nichols V, Marrocco A, Thomas AJ, Mitsias PD, Malik GM: Magnesium sulfate therapy after aneurysmal subarachnoid hemorrhage. J Neurosurg 96:510-514, 2002.
94. Waddell G: Moving the critically ill. Nurs Times 71:1937-1939, 1975.
95. Wypij D, Newburger JW, Rappaport LA, du Plessis AJ, Jonas RA, Wernovsky G, Lin M, Bellinger DC: The effect of duration of deep hypothermic circulatory arrest in infant heart surgery on late neurodevelopment: The Boston Circulatory Arrest Trial. J Thorac Cardiovasc Surg 126:1397-1403, 2003.